These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32024682)

  • 21. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
    Hodge RG; Schaefer A; Howard SV; Der CJ
    Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations.
    Nikaido M; Kakiuchi N; Miyamoto S; Hirano T; Takeuchi Y; Funakoshi T; Yokoyama A; Ogasawara T; Yamamoto Y; Yamada A; Setoyama T; Shimizu T; Kato Y; Uose S; Sakurai T; Minamiguchi S; Obama K; Sakai Y; Muto M; Chiba T; Ogawa S; Seno H
    Gastric Cancer; 2021 Sep; 24(5):1102-1114. PubMed ID: 33961152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients.
    Muretto P; Ruzzo A; Pizzagalli F; Graziano F; Maltese P; Zingaretti C; Berselli E; Donnarumma N; Magnani M
    Ann Oncol; 2008 Mar; 19(3):516-9. PubMed ID: 17986624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
    Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
    JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DGC-specific
    Nishizawa T; Nakano K; Harada A; Kakiuchi M; Funahashi SI; Suzuki M; Ishikawa S; Aburatani H
    Oncotarget; 2018 May; 9(33):23198-23207. PubMed ID: 29796182
    [No Abstract]   [Full Text] [Related]  

  • 27. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease.
    Iyer P; Moslim M; Farma JM; Denlinger CS
    Transl Gastroenterol Hepatol; 2020; 5():52. PubMed ID: 33073047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands.
    Suriano G; Oliveira C; Ferreira P; Machado JC; Bordin MC; De Wever O; Bruyneel EA; Moguilevsky N; Grehan N; Porter TR; Richards FM; Hruban RH; Roviello F; Huntsman D; Mareel M; Carneiro F; Caldas C; Seruca R
    Hum Mol Genet; 2003 Mar; 12(5):575-82. PubMed ID: 12588804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy.
    Garziera M; De Re V; Geremia S; Seruca R; Figueiredo J; Melo S; Simões-Correia J; Caggiari L; De Zorzi M; Canzonieri V; Cannizzaro R; Toffoli G
    Clin Exp Med; 2013 May; 13(2):149-57. PubMed ID: 22543498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression.
    Monster JL; Kemp LJS; Gloerich M; van der Post RS
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188719. PubMed ID: 35307354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between the CDH1-472delA and -160C>A polymorphisms and diffuse and intestinal gastric cancer in a Mexican population.
    Bustos-Carpinteyro AR; Delgado-Figueroa N; Santiago-Luna E; Magaña-Torres MT; Sánchez-López JY
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
    An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
    Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
    Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
    Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using fruitflies to help understand the molecular mechanisms of human hereditary diffuse gastric cancer.
    Caldeira J; Pereira PS; Suriano G; Casares F
    Int J Dev Biol; 2009; 53(8-10):1557-61. PubMed ID: 19247957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
    Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
    J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models.
    Shimada S; Akiyama Y; Mogushi K; Ishigami-Yuasa M; Kagechika H; Nagasaki H; Fukamachi H; Yuasa Y; Tanaka S
    Br J Cancer; 2018 Apr; 118(7):972-984. PubMed ID: 29527007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
    Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.